|
|
|
|
Vol. 59, Issue 3, 636-645, March 2001
Oncology and Molecular Endocrinology Research Center, Laval
University Hospital (CHUL) and Laval University, Quebec, Canada (O.B.,
C.A., I.M., M.V., K.H., F.L., D.W.H., C.L., A.L.); MRC Group in
Molecular Endocrinology, CHUL Research Center, Laval University,
Quebec, Canada (F.L., C.L., A.B.)
EM-652 (SCH 57068) is a new orally active antiestrogen that
demonstrates pure antagonistic effects in the mammary gland and endometrium. In vivo studies have shown that EM-652 is primarily glucuronidated at the 7-hydroxy position in rats and that the metabolite is present in the plasma of female monkeys and human subjects after EM-800 (SCH 57050) or EM-652·HCl oral administration. Using hepatic microsomes from rat, monkey, and human, the formation of
two EM-652 monoglucuronides at positions 4' and 7 was demonstrated by a
liquid chromatographic tandem mass spectrometric method. Although no
difference in EM-652 conjugation was observed between male and female
monkey livers, an interindividual variation of hepatic EM-652
glucuronidation was shown with female human donors. Using microsome
preparations from human embryonic kidney 293 cells stably expressing
each of the 12 human and 11 monkey UGT enzymes cloned to date, the two
EM-652-monoglucuronides were detected after incubation with microsomes
containing human UGT1A1, UGT1A3, UGT1A8, UGT1A9, and monkey monUGT1A01,
monUGT1A03, and monUGT1A09. Despite human UGT1A1 and monkey monUGT1A09
favored formation of EM-652-7-glucuronide, other active UGT1A enzymes
formed both 4'- and 7-glucuronide derivatives in equal amounts. Kinetic
analysis of EM-652 glucuronidation by these enzymes showed Michaelis
constant (Km) values between 36 and 302 µM
for EM-652-4'-glucuronide and 19 and 233 µM for
EM-652-7-glucuronide. The present results demonstrate the importance
of UGT1A isoforms, mainly UGT1A1, for EM-652 metabolism in humans.
This article has been cited by other articles:
![]() |
S. Chouinard, M. Tessier, G. Vernouillet, S. Gauthier, F. Labrie, O. Barbier, and A. Belanger Inactivation of the Pure Antiestrogen Fulvestrant and Other Synthetic Estrogen Molecules by UDP-Glucuronosyltransferase 1A Enzymes Expressed in Breast Tissue Mol. Pharmacol., March 1, 2006; 69(3): 908 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Martineau, A. Tchernof, and A. Belanger AMINO ACID RESIDUE ILE211 IS ESSENTIAL FOR THE ENZYMATIC ACTIVITY OF HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A10 (UGT1A10) Drug Metab. Dispos., April 1, 2004; 32(4): 455 - 459. [Abstract] [Full Text] [PDF] |
||||